BLS Pharmaceuticals Limited Stock: price and insider trades · Australia
1 insider bought shares over the last 90 days, the latest by Mr Jason Hine, filed 27 Oct 2026.
BLS Pharmaceuticals Limited: what insiders have been doing
BLS Pharmaceuticals Limited is a Health Care company. Its directors and officers file their transactions with ASX. Over the twelve months to 27 October 2026, 4 filings were filed, from 4 insiders.
Only purchases show up on the open market, 1 purchase in all, filed by 1 insider. The totals do not cover 1 filing with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The buyers include 1 senior executive.
The last insider purchase was made public on 27 October 2026, 12 days ago.
Compared with its exchange (1,602 companies, median 5 filings), a count of 4 filings is below the norm. Since 2026, the database holds 1 purchase and no sales by insiders of the company.
In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended June 2026 · cache
- 700,000 sharesShareASXASX:2924-03153880-2A1706463Canonical exit: 21 Jan 2027 (T+90)
- ShareASXASX:2924-03147443-2A1703626
- ShareASXISIN AU0000477796ASX:2924-03146608-2A1703266
- ShareASXASX:2924-03135420-2A1697127
4 of 4 declarations
About BLS Pharmaceuticals Limited
BLS is a company listed on the XASX, specializing in the financial sector. It provides various financial services to clients.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
